NASDAQ · OSA
ProSomnus, Inc.
$0.47$0.00 (0.0%)
ProSomnus, Inc.’s quoted price sits in the lower half of its reported 52-week range, 6.0% below the high.
Loading market information…
OTC · FLURF · USD
Stock price, earnings
Quote as of Dec 16, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow FluroTech Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
FluroTech Ltd. operates as a technology and marketing firm, primarily focused on advancing and commercializing various innovations within the pandemic defense industry. The company is responsible for developing the FluroTest SARS-CoV-2 diagnostic, which is designed to pinpoint patients with active viral infections. Its headquarters are located in Calgary, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.47$0.00 (0.0%)
ProSomnus, Inc.’s quoted price sits in the lower half of its reported 52-week range, 6.0% below the high.
$0.07$0.00 (0.0%)
SugarBud Craft Growers Corp.’s quoted price sits in the lower half of its reported 52-week range, 77.44% below the high.
$1.16$0.00 (0.0%)
Evolva Holding S.A.’s quoted price sits in the lower half of its reported 52-week range, 32.16% below the high.
$0.00$0.00 (0.0%)
Medical Services International Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Laxai Pharma, Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.01-$0.01 (-68.71%)
Lotus Ventures Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.29% below the high.
$0.01+$0.01 (+100.0%)
Alseres Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Achiko AG: Healthcare · Medical - Healthcare Information Services.
